Physician profile
Christopher J Gannon
NPI 1962500207
$10,016.72
in general payments reported to CMS, 2019-2025
11 companies · $2,025 in 2025
The $2,025 reported for 2025 was more than what 81% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,191 · 2020: $197 · 2021: $556 · 2022: $209 · 2023: $119 · 2024: $5,720 · 2025: $2,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,999 · Travel and Lodging: $2,530 · Food and Beverage: $1,198 · Education: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,999.03 |
| Travel and Lodging | $2,529.76 |
| Food and Beverage | $1,198.41 |
| Education | $1,137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $3,204.09 | 2024 | |
| Intuitive Surgical, INC. | $1,841.17 | 2024 | |
| Ethicon US, LLC | $1,751.80 | 2019-2025 | Stratafix, Vistaseal, Monocryl |
| Histosonics, INC. | $1,698.31 | 2025 | |
| Biom'Up Sa | $687.54 | 2019 | |
| Medical Device Business Services, INC. | $217.40 | 2024 | |
| Boston Scientific Corporation | $209.13 | 2019 | |
| Allergan, INC. | $125.00 | 2019 | |
| Aroa Biosurgery Incorporated | $124.18 | 2024 | |
| Davol INC. | $100.00 | 2024 | Phasix Mesh |
| Iovance Biotherapeutics, INC. | $58.10 | 2025 | Amtagvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Gannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.